Clinical trials
Dyslipidemias trials in Malaysia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Amgen | 2 |
| Tanabe Pharma Corporation | 2 |
| Cardiovascular Advancement and Research Excellence Institute | 1 |
| National University of Malaysia | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
| Sanofi | 1 |
| University of Malaya | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 13 |
| Hypercholesterolemia | 6 |
| Cardiovascular Diseases | 4 |
| Hyperlipidemias | 4 |
| Hypertension | 3 |
| Aortic Valve Stenosis | 2 |
| Diabetes Mellitus | 2 |
| Heart Failure | 2 |
| Hyperlipoproteinemia Type II | 2 |
| Renal Insufficiency, Chronic | 2 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.